Depression and quality of life in patients with coronary artery disease

References

• Koike AK, Unutzer J, Wells KB. Improving the care for depression in patients with comorbid medical illness. Arn. I BychMtry159, 1738–1745 (2002).
   Google Scholar
• Simon GE. Social and economic burden of mood disorders. Biol. Psychiatry54, 208–215 (2003).
   PubMed Web of Science ®Google Scholar
• Katon WJ. Clinical and health services relationships between major depression, depressive symptoms and general medical illness. Biol. Rychiatiy54, 216–226 (2003).
   PubMed Web of Science ®Google Scholar
• •Reviews the literature on the relationship between depression and adverse health behaviors, treatment adherence and medical utilization and costs.
   Google Scholar
• Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAIVIA 262, 914–919 (1989).
   Google Scholar
• ••Classic paper demonstrating the additiveeffect of depression in decreasing quality of life in patients with chronic medical illness.
   Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91, 999–1005 (1995).
   PubMed Web of Science ®Google Scholar
• Lane D, Carroll D, Ring C, Beevers DG, Lip GYH. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom. Med. 63,221-230 (2001).
   Google Scholar
• Ladwig KH, Roll G, Briehardt G, Budde T, Borggrefe M. Post infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 343, 20–23 (1994).
   Google Scholar
• Mayou RA, Gill D, Thompson DR et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom. Med. 62, 212–219 (2000).
   PubMed Web of Science ®Google Scholar
• Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RR Relation between depression after coronary artery bypass surgery and 12 month outcome: a prospective study. Lancet 358, 1766–1771 (2001).
   PubMed Web of Science ®Google Scholar
• Pirraglia PA, Peterson JC, Williams-Russo P, Gorkin L, Charlson ME. Depressive symptomatology in coronary artery bypass graft surgery patients. Int. J. Geriatc Psych. 14,668–680 (1999).
   Google Scholar
• Blumenthal JA, Lett HS, Babyak MA et al Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362,604–609 (2003).
   PubMed Web of Science ®Google Scholar
• Ladwig KH, Lehmacher W Roth R, Breithardt G, Budde TH, Borggrefe M. Factors which provoke post infarction depression: results from the Post-Infarction Late Potential Study (PILP). I Psychosom. Res. 36,723–729 (1992).
   PubMed Web of Science ®Google Scholar
• Brummett BH, Babyak MA, Barefoot JC et al Social support and hostility as predictors of depressive symptoms in cardiac patients one month after hospitalization: a prospective study. Psychosom. Med 60, 707–713 (1998).
   PubMed Web of Science ®Google Scholar
• Gonzalez MB, Snyderman TB, Colket JT et al Depression in patients with coronary artery disease. Depmssion 4,57–62 (1996).
   PubMedGoogle Scholar
• Lespérance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom. Med. 58,99–110 (1996).
   PubMed Web of Science ®Google Scholar
• •Provides evidence about the clinical course of depression before and after myocardial infarction in a large number of patients.
   Google Scholar
• Koenig HG. Differences in psychosocial and health correlates of major and minor depression in medically ill older adults. J. Aim Geriatc Soc. 45,1487–1495 (1997).
   PubMed Web of Science ®Google Scholar
• Bush DE, Ziege1stein RC, Tayback M et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol 88, 337–341 (2001).
   Google Scholar
• Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen. Hosp. Psych. 18,61-65 (1996).
   Google Scholar
• Anda R, Williamson D, Jones D et al. Depressed affect, hopelessness and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 4,285–294 (1993).
   PubMed Web of Science ®Google Scholar
• Ford DE, Mead LA, Chang PP, Cooper- Patrick L, Wang N-Y, Klag MJ. Depression is a risk factor for in men. The Precursors Study. Arch. Intern Med 158,1422–1426 (1998).
   PubMed Web of Science ®Google Scholar
• Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom. Med 65,201–210 (2003).
   PubMed Web of Science ®Google Scholar
• ••Systematic review which provides evidence that depression is a risk factor for development of coronary artery disease (CAD).
   Google Scholar
• Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am. Rev Med 23, 51–61 (2002).
   Google Scholar
• Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JA M4 270,1819–1825 (1993).
   Google Scholar
• Ariyo AA, Haan M, Tangen CM et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 102,1773–1779 (2000).
   PubMed Web of Science ®Google Scholar
• Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. 5-year risk of cardiac mortality in relation to initial severity and 1 year changes in depression symptoms after myocardial infarction. Circulation 105,1049–1053 (2002).
   PubMed Web of Science ®Google Scholar
• ••Investigation provides evidence for thelink between depression and elevated mortality risk in patients with CAD.
   Google Scholar
• Wassertheil-Smoller S, Shumaker S, Ockene J et al Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch. Intern. Med. 164,289–298 (2004).
   Google Scholar
• Lespérance F, Frasure-Smith N, Juneau M, Theroux P Depression and 1-year prognosis in unstable angina. Arch. Intern. Med. 160,1354-1360 (2000).
   Google Scholar
• Strik JJMH, Denollet J, Lousberg R, Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased healthcare comsumption after myocardial infarction. j Aim Coll Cardiol 42 (10), 1801–1807 (2003).
   PubMed Web of Science ®Google Scholar
• Irvine J, Basinski A, Baker B et al Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom. Med. 61,729–737 (1999).
   PubMed Web of Science ®Google Scholar
• Kaufmann MW Fitzgibbons JP, Suusman EJ et al Relation between myocardial infarction, depression, hostility and death. Am. Hear t J. 138,549-554 (1999).
   Google Scholar
• Lane D, Carroll D, Lip GYH. Anxiety, depression and prognosis after myocardial infarction. Is there a causal association? Am. Coll. Carrliol 42 (10), 1808–1810 (2003).
   Google Scholar
• Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Epidemiology, biology and treatment. Arch. Gen fiychiatry55, 580–592 (1998).
   Google Scholar
• ••An excellent review of the evidence for pathophysiological alterations related to cardiovascular disease in patients with depression.
   Google Scholar
• Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol. Psychiatry 54,248–261 (2003).
   Google Scholar
• Tro)der RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclemsis 26,151–162 (1977).
   PubMedGoogle Scholar
• Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur Heart 19\(Suppl. 9, F62—F71 (1998).
   Google Scholar
• Carney RM, Blumenthal JA, Stein PK et al Depression, heart rate variability and acute myocardial infarction. Circulation 104, 2024–2028 (2001).
   PubMed Web of Science ®Google Scholar
• Appels A, Bar FVV, Bar J, Bruggemen C, de Baets M. Inflammation, depressive symptomatology and coronary artery disease. Psychosom. Med. 62,601–605 (2000).
   Google Scholar
• von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom. Med. 63,531–544 (2001).
   Google Scholar
• Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adult obesity. Pediatrics 109,497–504 (2002).
   Google Scholar
• Rosal MC, Ockene JK, Ma Y et al. Behavioral risk factors among members of a health maintenance organization. Prey Med. 33,586–594 (2001).
   PubMedGoogle Scholar
• Glassman A, Helzer J, Covey LS et al. Smoking, smoking cessation and major depression. JAMA 264,1546–1549 (1990).
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160,2101–2107 (2000).
   Google Scholar
• •Demonstrates the negative effects of depression and anxiety on adherence to medical treatment.
   Google Scholar
• Carney RM, Freedland KE, Eisen SA, Rich MW Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 14,88–90 (1995).
   Google Scholar
• Lane D, Carroll D, Ring C, Beevers DG, Lip GHY. Predictors of attendance at cardiac rehabilitation after myocardial infarction. j fiychosom. Res. 51, 497–501(2001).
   Google Scholar
• Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch. Intern. Med.160(12), 1818–1823 (2000).
   Google Scholar
• Romanelli J, Fauerbach JA, Bush DE, Ziegelstein RC. The significance of depression in older patients after myocardial infarction. j Am. Geriatr Soc. 50,817–822 (2002).
   PubMed Web of Science ®Google Scholar
• Wenger NK. Improvement of quality of life in the framework of cardiac rehabilitation. In: Clinical Cardiac Rehabilitation. A Carrliologisti Guide. Second Edition. Pashkow FJ, Dafoe WA (Eds). Williams & Wilkins, MD, USA, 43–51 (1999).
   Google Scholar
• Lespérance F, Frasure-Smith N. The seduction of death. Psychosom. Med. 61, 18–19 (1999).
   PubMedGoogle Scholar
• Swenson JR, Clinch JJ. Assessment of quality of life in patients with cardiac disease: the role of psychosomatic medicine. Psychosom. Res. 48,405–415 (2000).
   PubMed Web of Science ®Google Scholar
• ••Reviews the concept of quality of life andits relationship to psychological and social factors in patients with cardiac disease.
   Google Scholar
• Ware JE, Sherbourne CD. The MOS 36- item Short-form Health Survey (SF-36). Conceptual framework and item selection. Med. Cary 30,473–483 (1992).
   Google Scholar
• Hopman WM, Towheed T, Anastassiades T et al Canadian normative data for the SF-36 health survey. CM4J163, 265–271 (2000).
   Google Scholar
• Miller WV, Keitner GI, Schatzberg AF et al The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. Clin. PTchiatry59, 608–619 (1998).
   Google Scholar
• Komaroff AL, Fagioli LR, Doolittle TH et al Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am. Med.101, 281–290 (1996).
   PubMed Web of Science ®Google Scholar
• Pilote L, Lauzon C, Huynh T et al. Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography. Arch. Intern Med. 162,553–559 (2002).
   PubMedGoogle Scholar
• Rinfret S, Grines CL, Cosgrove RS et al. Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial. Am. Coll Carrliol 38,1614–1621 (2001).
   PubMed Web of Science ®Google Scholar
• Swenson JR, O'Connor CM, Barton D et al Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. AM. I Carcliol. 92,1271–1276 (2003).
   PubMed Web of Science ®Google Scholar
• ••Substudy of the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) study examines the effect of antidepressant treatment on quality of life in a 24-week randomized, controlled trial of sertraline in patients with acute myocardial infarction or unstable angina.
   Google Scholar
• Hunt SM, McKenna SP, McEwan J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. j Epidenriol Commun. Health 34,281–286 (1980).
   PubMed Web of Science ®Google Scholar
• Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med. Cate 19,787–805 (1981).
   Google Scholar
• Kim C, Bernstein SJ. Quality of life assessment for chronic stable angina. Expert Rev. Pharmacoeconomics Outcomes Res. 3 (5), 637–650 (2003).
   PubMedGoogle Scholar
• Spertus JA, Winder JA, Dewhurst T et al Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J.Ain. Coll Catrliol 25,333–341 (1995).
   PubMed Web of Science ®Google Scholar
• Valenti L, Lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality of life after acute myocardial infarction. Qual Life Res. 5 (1), 151–161 (1996).
   Google Scholar
• Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life. The Heart and Soul Study. JAIVIA 290, 215–221 (2003).
   Google Scholar
• Rumsfeld JS, Magid DJ, Plomondon ME et al. History of depression, angina and quality of life after acute coronary syndromes. Am. Heart 145,493–499 (2003).
   PubMed Web of Science ®Google Scholar
• Spiegel D. Cancer and depression. BE J Pwchiatry168\(Suppl. 30), 109–116 (1996).
   Google Scholar
• Frasure-Smith N, Lespérance F, Gravel G et al. Social support, depression and mortality during the first year after myocardial infarction. Circulation 101, 1919–1924 (2000).
   PubMed Web of Science ®Google Scholar
• •This study provides evidence of the link between social support, depression and mortality in patients with CAD.
   Google Scholar
• Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. The Enhancing Recovery in Coronory Heart Disease Patients (ENRICHD) randomized trial. JA/V/A 289,3106-3116 (2003).?A large randomized, controlled trial of cognitive-behavioral therapy and antidepressant medication in patients with coronary disease and depression or social isolation. It failed to show a beneficial effect of the intervention on mortality.
   Google Scholar
• Koszycki D, Lafontaine S, Frasure-Smith N, Swenson R, Lespérance E An open label trial of interpersonal psychotherapy, with or without antidepressant medication, in depressed patients with coronary disease. Psychosomatics (2004) (In Press).
   Google Scholar
• Gill D, Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. J Bychosom Res. 47, 131–143 (1999).
   PubMed Web of Science ®Google Scholar
• ••Systematic review which provides evidencethat antidepressant medications are effective in patients with chronic medical illnesses.
   Google Scholar
• Roose SR Treatment of depression in patients with heart disease. Bid Psychiatry 54,262–268 (2003).
   Google Scholar
• Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EGV. Cardiovascular effects of bupropion in depressed patients with heart disease. Am. J fiychiatry148, 512–516 (1991).
   PubMed Web of Science ®Google Scholar
• Askinazi C. SSRI treatment of depression with comorbid cardiac disease. Am. J fiychiatry153, 135–136 (1996).
   PubMedGoogle Scholar
• Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am. J fiychiatry155, 660–665 (1998).
   Google Scholar
• Roose SP, Laghrissi-Thode F, Kennedy JS et al Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAIVIA 279, 287–291 (1998).
   PubMed Web of Science ®Google Scholar
• Shapiro PA, Lespérance F, Frasure-Smith N et al An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Am. Heart 137, 1100–1106 (1999).
   PubMed Web of Science ®Google Scholar
• Strik JJMH, Honig A, Lousberg R et al Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Pwchosom. Med. 62,783–789 (2000).
   PubMed Web of Science ®Google Scholar
• Glassman AH, O'Connor CM, Califf RM et al Sertraline treatment of major depression in patients with acute MI or unstable angina. JAIVIA 288,701–709 (2002).
   PubMed Web of Science ®Google Scholar
• ••Provides the results of the SADHART trialwhich is the largest randomized, controlled trial of antidepressant medication in patients with acute myocardial infarction or unstable angina. SADHART demonstrated the cardiac safety of sertraline and the efficacy of sertaline treatment for depression, particularly in the groups of patients with recurrent depression.
   Google Scholar
• Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk—benefit reconsidered. JAIVIA 269,2673–2675 (1993).
   Google Scholar
• McElroy SL, Keck PE, Friedman LM. Minimizing and managing antidepressant side effects. J Clin. Psych. 56\(Suppl. 2), 49–55 (1995).
   Google Scholar
• Beliles K, Stoudemire A. Psychopharmacologic treatment of depression in the medically ill. Psychosomatics 39, S2—S19 (1998).
   Google Scholar
• •Review of the clinical considerations when prescribing antidepressant medication to patients with medical illness.
   Google Scholar
• Sayal KS, Duncan-McConnell DA, McConnell HW, Taylor DM. Psychotropic interactions with warfarin. Acta PsychiatE Land. 102,250–255 (2000).
   PubMed Web of Science ®Google Scholar
• Linden W Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch. Intern. Med. 156,745–752 (1996).
   PubMedGoogle Scholar
• Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104,1894–1898 (2001).
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Glassman AH, Malinin Al et al Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. The SADHART platelet substudy. Circulation 108,939–944 (2003).
   PubMed Web of Science ®Google Scholar
• Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin. Bychopharmacol 20, 137–140 (2000).
   PubMed Web of Science ®Google Scholar
• Coulehan J, Schulberg HC, Block MR, Maedonia MJ, Rodriguez E. Treating depressed primary care patients improves their physical, mental and social functioning. Arch. Intern Med. 157, 1113–1120 (1997).
   Google Scholar
• Lespérance F, Frasure-Smith N. Depression and coronary artery disease: time to move from observation to trials. CM4J168 (5), 570–571 (2003).
   Google Scholar
• Kaufmann PG. Depression in cardiovascular disease: can the risk be reduced? Biol. Psychiatry 54,187–190 (2003).
   Google Scholar